US4871747A
Expired / Lapsed
US
⏱️ 0.0 years remaining
3-Amino-4,5-dihydroxypiperidines, process for their preparation and their use
Assignee: Bayer AG
•
Filing: 1986-12-03
•
Granted: 1989-10-03
•
Expires: 2006-12-03
Abstract
Abstract A 3-amino-4,5-dihydroxy-piperidine compound of the formula (I) ##STR1## in which R 1 represents hydrogen, alkyl having up to 8 carbon atoms, aralkyl having 7 to 14 carbon atoms, or represents a group of the formula ##STR2## R 4 denotes straight-chain or branched alkyl having up to 8 carbon atoms, straight-chain or branched alkoxy having up to 8 carbon atoms, or aralkoxy having up to 10 carbon atoms, and R 2 and R 3 represent hydrogen or represent the group NHR 5 , R 5 having the same meaning as R 1 and being identical to or different from the latter, with the proviso that, in every case, one substituent of R 2 or R 3 represents hydrogen and the other substituent of R 2 or R 3 represents NHR 5 , and physiologically acceptable salts thereof. Such compound is useful to treat prediabetes, gastritis, constipation, caries, atherosclerosis, obesity, diabetes and hyperlipoproteinaemia.
Inventors
- 👤 Gunther Kinast
- 👤 Matthias Schuller
- 👤 Theo Schroder
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-04 22:15
CPC Classifications
C; C07; C07D; C07D211/00; C07D211/04; C07D211/06; C07D211/08; C07D211/18; C07D211/20; C07D211/22; C07D491/00; C07D491/02; C07D491/04; C07D211/36; C07D211/40; C07D211/44; C07D211/46; C07D211/56; C07H; C07H13/00; C07H13/02; C07H13/04; C07H13/12
Claims Analysis
Total Claims: 20
Claim 1
Independent Claim
134 words
A 3-amino-4,5-dihydroxypiperidine of the formula ##STR35## in which R 1 represents hydrogen, alkyl having up to 8 carbon atoms, aralkyl having 7 to 14 carbon atoms, or represents a group of the formula ##STR36## R 4 denotes straight-chain or branched alkyl having up to 8 carbon atoms, straight-chain or branched alkoxy having up to 8 carbon atoms, or aralkoxy having up to 10 carbon atoms, and R 2 and R 3 represent hydrogen or represent the group NHR 5 , R 5 having the same meaning as R 1 and being identical to or different from the latter, with the proviso that, in every case, one substituent of R 2 or R 3 represents hydrogen and the other substituent of R 2 or R 3 represents NHR 5 , and physiologically acceptable salts thereof.
Claim 2
Dependent Claim
134 words
A 3-amino-4,5-dihydroxypiperidine of the formula ##STR35## in which R 1 represents hydrogen, alkyl having up to 8 carbon atoms, aralkyl having 7 to 14 carbon atoms, or represents a group of the formula ##STR36## R 4 denotes straight-chain or branched alkyl having up to 8 carbon atoms, straight-chain or branched alkoxy having up to 8 carbon atoms, or aralkoxy having up to 10 carbon atoms, and R 2 and R 3 represent hydrogen or represent the group NHR 5 , R 5 having the same meaning as R 1 and being identical to or different from the latter, with the proviso that, in every case, one substituent of R 2 or R 3 represents hydrogen and the other substituent of R 2 or R 3 represents NHR 5 , and physiologically acceptable salts thereof.
Claim 3
Dependent Claim
127 words
A 3-amino-4,5-dihydroxypiperidine according to claim 1, in which R 1 represents hydrogen or alkyl having up to 6 carbon atoms, or R 1 represents benzyl or represents a group of the formula ##STR37## in which R 4 denotes straight-chain or branched alkyl having up to 4 carbon atoms, straight-chain or branched alkoxy having up to 4 carbon atoms, or benzyloxy, and R 2 and R 3 represent hydrogen or represent NHR 5 , R 5 having the same meaning as R 1 and being identical to or different from the latter, with the proviso that, in every case, one substituent of R 2 or R 3 represents hydrogen and the other substituent of R 2 or R 3 represents NHR 5 , and physiologically acceptable salts thereof.
Claim 4
Dependent Claim
91 words
A 3-amino-4,5-dihydroxypiperidine according to claim 1, in which R 1 represents hydrogen, alkyl having up to 4 carbon atoms, benzyl, acetyl or benzyloxycarbonyl, and R 2 and R 3 represent hydrogen or represent the group NHR 5 , R 5 having the same meaning as R 1 and being identical to or different from the latter, with the proviso that, in every case, one substituent of R 2 or R 3 represents hydrogen and the other substituent of R 2 R 3 represents NHR 5 , and physiologically acceptable salts thereof.
Claim 5
Dependent Claim
12 words
A 3-amino-4,5-dihydroxypiperidine according to claim 1, having the manno configuration (Ia) ##STR38##
Claim 6
Dependent Claim
12 words
A 3-amino-4,5-dihydroxypiperidine according to claim 1, having the gluco configuration (Ib) ##STR39##
Claim 7
Dependent Claim
18 words
A 3-amino-4,5-dihydroxypiperidine according to claim 1 selected from the group consisting of 2-acetamido-1,5-imino-1,2,5-trideoxy-D-mannitol, 2amino-1,5-imino-1,2,5-trideoxy-D-mannitol, 2-acetamido-1,2-dideoxy-nojirimycin, 2-acetamido-N-benzyl-1,2-dideoxy-nojirimycin, and 2-acetamido-N-methyl-1,2-dideoxy-nojirimycin.
Claim 8
Dependent Claim
32 words
A method of treating prediabetes in a patient which comprises administering to said patient a therapeutically effective amount of a 3-amino-4,5-dihydroxypiperidine according to claim 1 sufficient to treat prediabetes in said patient.
Claim 9
Dependent Claim
22 words
A method according to claim 7, wherein the 3-amino-4,5-dihydroxypiperidine is selected from the group consisting of 2-acetamido-1,5-imino-1,2,5-trideoxy-D-mannitol, 2-amino-1,5-imino-1,2,5-trideoxy-D-mannitol, 2-acetamido-1,2-dideoxy-nojirimycin, 2-acetamido-N-benzyl-1,2-dideoxy-nojirimycin, and 2-acetamido-N-methyl-1,2-dideoxy-nojirimycin.
Claim 10
Dependent Claim
22 words
A medicament composition comprising a pharmaceutically effective amount of a 3-amino-4,5-dihydroxypiperidine according to claim 1 in admixture with a pharmaceutically acceptable carrier.
Claim 11
Dependent Claim
22 words
A unit dose of a composition according to claim 8 in the form of a tablet, capsule, suspension, solution, syrup or elixir.
Claim 12
Dependent Claim
32 words
A method of treating gastritis in a patient which comprises administering to said patient a therapeutically effective amount of a 3-amino-4,5-dihydroxypiperidine according to claim 1 sufficient to treat gastritis in said patient.
Claim 13
Dependent Claim
31 words
A method of treating constipation in a patient which comprisesadministering to said patient a therapeutically effective amount of a 3-amino-4,5-dihydroxypiperidine according to claim 1 sufficient to treat constipation in said patient.
Claim 14
Dependent Claim
32 words
A method of treating caries in a patient which comprises administering to said patient a therapeutically effective amount of a 3-amino-4,5-dihydroxypiperidine according to claim 1 sufficient to treat caries in said patient.
Claim 15
Dependent Claim
32 words
A method of treating artherosclerosis in a patient which comprises administering to said patient a therapeutically effective amount of a 3-amino-4,5-dihydroxypiperidine according to claim 1 sufficient to treat artherosclerosis in said patient.
Claim 16
Dependent Claim
32 words
A method of treating obesity in a patient which comprises administering to said patient a therapeutically effective amount of a 3-amino-4,5-dihydroxypiperidine according to claim 1 sufficient to treat obesity in said patient.
Claim 17
Dependent Claim
32 words
A method of treating diabetes in a patient which comprises administering to said patient a therapeutically effective amount of a 3-amino-4,5-dihydroxypiperidine according to claim 1 sufficient to treat diabetes in said patient.
Claim 18
Dependent Claim
32 words
A method of treating hyperlipoproteinaemia in a patient which comprises administering to said patient a therapeutically effective amount of a 3-amino-4,5-dihydroxypiperidine according to claim 1 sufficient to treat hyperlipoproteinaemia in said patient.
Claim 19
Dependent Claim
34 words
A 3-amino-4,5-dihydroxypiperidine according to claim 1, wherein the salt is selected form the group consisting of hydrochlorides, hydrobromides, sulphates, hydrogen sulphates, hydrogen phosphates, hydrogen carbonates, carbonates, phosphates, acetates, maleates, citrates, fumarates, oxalates and benzoates.
Claim 20
Dependent Claim
31 words
A method of increasing the ratio of desired low-fat meat/undesired fat in an animal comprising administering to said animal a fat reducing effective amount of a 3-amino-4,5-dihdyroxypiperidine according to claim 1.
References Cited (Backward Citations)
US4182767A
Cited
EP0000947A1
Cited
US4220782A
Cited
US4278683A
Cited
US4328233A
Cited
US4611058A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1992-10-02 | 1993-04-03 | 1993-10-03 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1996-10-02 | 1997-04-03 | 1997-10-03 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2000-10-02 | 2001-04-03 | 2001-10-03 | $7700.00 | Window Closed / Lapsed |